Evidence map›Paper›PMID 38066593›Full record

ArticleThe Journal of clinical endocrinology and metabolism2024

Sex Differences in Branched-chain Amino Acid and Tryptophan Metabolism and Pathogenesis of Youth-onset Type 2 Diabetes.

Natalie Hernandez, Yuliya Lokhnygina, Megan Elizabeth Ramaker, Olga Ilkayeva, Michael J Muehlbauer, Matthew L Crawford, Russell P Grant, Daniel S Hsia, Nina Jain, James R Bain and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Natalie HernandezDivision of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0009-0007-9491-5891
Yuliya LokhnyginaDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.
Megan Elizabeth RamakerDuke Molecular Physiology Institute (DMPI), Duke University Medical Center, Durham, NC 27701, USA.
Olga IlkayevaDuke Molecular Physiology Institute (DMPI), Duke University Medical Center, Durham, NC 27701, USA.
Michael J MuehlbauerDuke Molecular Physiology Institute (DMPI), Duke University Medical Center, Durham, NC 27701, USA.
Matthew L CrawfordDepartment of Research and Development, LabCorp, Burlington, NC 27215, USA.
Russell P GrantDepartment of Research and Development, LabCorp, Burlington, NC 27215, USA.
Daniel S HsiaClinical Trials Unit, Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Nina JainDivision of Endocrinology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC 27514, USA.
James R BainDuke Molecular Physiology Institute (DMPI), Duke University Medical Center, Durham, NC 27701, USA.
Sarah ArmstrongDuke Clinical Research Institute, Duke University Medical Center, Durham, NC 27701, USA.
Christopher B NewgardDuke Molecular Physiology Institute (DMPI), Duke University Medical Center, Durham, NC 27701, USA.
Michael FreemarkDivision of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, NC 27710, USA.
Pinar Gumus BalikciogluDivision of Pediatric Endocrinology and Diabetes, Duke University Medical Center, Durham, NC 27710, USA.
Duke University · USDuke Medical Center · USLabCorp (United States) · USPennington Biomedical Research Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
Pilot & Feasibility ProgramP30DK124723 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI P Darrell Neufer · 2020 to 2026
$11.0M
Predicting Newborn and Childhood Adiposity: An Integrated Omics ApproachR01DK117491 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LOWE, WILLIAM L, SCHOLTENS, DENISE M · 2018 to 2022
$2.8M
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic diseaseR01DK121710 · NIDDK · DUKE UNIVERSITY · PI HERMAN, MARK A, NEWGARD, CHRISTOPHER B · 2019 to 2022
$2.7M
Biomarkers of Dietary Intake and Exposure Data Coordinating CenterU24DK129557 · NIDDK · DUKE UNIVERSITY · PI CHAKRABORTY, HRISHIKESH · 2021 to 2025
$2.6M
Serotonin as a Novel Biomarker for Progression to Type 2 Diabetes in Obese AdolescentsK23DK117067 · NIDDK · DUKE UNIVERSITY · PI GUMUS BALIKCIOGLU, PINAR · 2018 to 2021
$847k
NIDDK NIH HHS K23 DK117067NIDDK NIH HHS P30 DK072476NIDDK NIH HHS P30 DK124723NIDDK NIH HHS R01 DK117491NIDDK NIH HHS R01 DK121710NIDDK NIH HHS U24 DK129557NIGMS NIH HHS U54 GM104940NIH HHS DK117067
6 · The paper itself

Abstract

objectivesInsulin resistance is associated with elevations in plasma branched-chain amino acids (BCAAs). BCAAs compete with aromatic amino acids including tryptophan for uptake into β cells. To explore relationships between BCAAs and tryptophan metabolism, adiposity, and glucose tolerance, we compared urine metabolites in overweight/obese youth with type 2 diabetes (T2D) with those in nondiabetic overweight/obese and lean youth.

methodsMetabolites were measured in 24-hour and first-morning urine samples of 56 nondiabetic adolescents with overweight/obesity, 42 adolescents with T2D, and 43 lean controls, aged 12 to 21 years. Group differences were assessed by Kruskal Wallis or ANOVA.

resultsGroups were comparable for age, pubertal status, and ethnicity. Youth with T2D were predominantly female and had highest percent body fat. BCAAs, branched-chain ketoacids (BCKAs), tryptophan, and kynurenine were higher in urine of subjects with T2D. There were no differences between lean controls and nondiabetic youth with overweight/obesity. T2D was associated with diversion of tryptophan from the serotonin to the kynurenine pathway, with higher urinary kynurenine/serotonin ratio and lower serotonin/tryptophan and 5-HIAA/kynurenine ratios. Urinary BCAAs, BCKAs, tryptophan, and ratios reflecting diversion to the kynurenine pathway correlated positively with metrics of body fat and hemoglobin A1c. Increases in these metabolites in the obese T2D group were more pronounced and statistically significant only in adolescent girls.

conclusionIncreases in urinary BCAAs and BCKAs in adolescent females with T2D are accompanied by diversion of tryptophan metabolism from the serotonin to the kynurenine pathway. These adaptations associate with higher risks of T2D in obese adolescent females than adolescent males.

Indexed as

Diabetes Mellitus, Type 2Pediatric ObesityAdolescentAmino Acids, Branched-ChainFemaleHumansKynurenineMaleOverweightSerotoninSex CharacteristicsTryptophanAmino Acids, Branched-ChainKynurenineSerotoninTryptophanBCAAsBCKAsobesitytryptophan-kynurenine-serotonin pathwayyouth-onset type 2 diabetes mellitus

Identifiers

PMID38066593
PMCPMC10940256
OpenAlexW4389499455

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.